The Team
Jackie Willmot
CEO & Co-founder
Jackie has 30+ years of experience in the healthcare industry including 13 years as a clinician and 15 years as an executive at Humana in the Innovation Center including 3 years working for a Humana Startup in the United Kingdom. Since leaving Humana in 2009 Jackie was trained by Steve Blank in his ‘Lean Launchpad Educators Class’ at Stanford University, has worked with 300+ startups, and serves as a business coach in a variety of capacities. She was a founding member and on the Board of Directors of the Network for Entrepreneurial Women and has worked with healthcare startups via the LaunchIt program where she works closely with Coulter, ExCITE, and I-Corps funded companies. Jackie is a Principal Investigator (PI) on an NIH funded initiative to create the XLeratorNetwork in the Southeast IDeA States and also sits on the External Review Board (ERB) for the NIH funded KYNETIC program, the University of Kentucky’s External Advisory Committee (EAC) for the NIH funded CCTS program, and the Review Panel for the Puerto Rico Science, Technology & Research Trust’s BioTech Accelerator Program “EnTRUST”. She is a Master’s prepared Perinatal Clinical Nurse Specialist and holds an MBA from the University of Louisville’s entrepreneurship program, a Master’s of Science from the University of Pittsburgh, and a Baccalaureate Nursing degree from Villa Maria College.
Bob Saunders
Chairman & Co-founder
Eugene Krentsel
CSO & VP of Strategic Partnership & Alliances
Prior to joining XLerateHealth, Dr. Krentsel served as Associate Vice President for Research and Innovation and Adjunct Professor of Entrepreneurship at the University of Louisville. He was responsible for the full range of activities in the discovery-innovation-translation-commercialization spectrum at UofL, including working with external groups in the public and private sectors to promote commercialization of university technologies and advancing industry engagement and entrepreneurship. Prior to being recruited to UofL in 2013, he served as Assistant Vice President for Entrepreneurship and Innovation Partnerships at Binghamton University in New York, where he helped develop and protect faculty intellectual property, paired researchers’ expertise with pressing market needs, and offered guidance to faculty and students interested in starting their own business.
Sebastian Alvim
Managing Director
Prior to stepping into the role of Managing Director, Sebastian joined the XLH team in Flint as Program Director and was instrumental in launching XLH’s 2nd location in Flint — which included collaborating with multiple healthcare stakeholders and investors in the region, building out and enhancing the programming, and creating technology tools that have improved the efficiencies and effectiveness of running the accelerator. Sebastian has extensive experience with evaluation of business strategy, commercial viability, and market analysis. He has advised 50+ healthcare startup companies successfully applying Lean Startup Methodology to help them develop, grow, and scale up their businesses. Sebastian also serves as a startup judge for the Michigan startup competition Invest360. Prior to XLH, he was a Co-founder of MyNurse, a home healthcare marketplace for caregivers and patients. Sebastian began his career at a British consultancy multinational firm, where he was responsible for human resource operations and strategic corporate advisory work (including change management, restructuring, and organizational assessment).
Kathy Weaver
Director, Special Projects
Kathy has over 30 years of experience in the health care industry. She has served in many different capacities throughout that time. She started her career as hospital nurse working for Johns Hopkins Hospital in their oncology center, performing patient care for adults with leukemia. She spent a decade working in the public sector for the State of Delaware leading a team of nurses and social workers completing eligibility for patients needing Long Term Care services, and building technology systems to support this work. In the early 2000’s she moved into the corporate space to work for Humana Inc. With Humana, Kathy continued to design technology systems for both clinical programs and provider connectivity. She was engaged in building innovation at Humana through joint ventures with the University of Miami, Pfizer and others. She was part of the core team that was the Humana start up that became Humana Europe, building clinical systems to support the work with the health economy in the United Kingdom. As the landscape changed in the health care industry with the passing of the Affordable Care Act in 2010, Kathy dove into work with EMR and Population Health companies in order to build a connected health care ecosystem for all participants. She left Humana in 2015, but continued her work with population health program and system development as an executive at both WellCare and Centene Corp. Currently, she continues to pursue entrepreneurial activities that help build a stronger more connected health care system as an independent contractor.
Marquicia Pierce Henderson
Director, Portfolio Commercialization
Dr. Marquicia Pierce Henderson, has 15+ years in life sciences and tech commercialization. She earned her PhD in Molecular Physiology with an emphasis in Engineering Management from Vanderbilt University. As an Industrial Postdoc at Michigan State University, she was an early member of an academic spin-out, Hibiskus Biopharma Inc. (acquired). During that time, she also earned her MBA at Northwood University. She was the life science specialist for the Michigan Small Business Development Center (SBDC) Tech Team, where she consulted founders of high-tech, high-growth companies across Michigan. Since then, she has supported several tech accelerators and national ecosystem partners with their programming as a Director, Entrepreneur in Residence, or Mentor/Coach. She is active in the investor ecosystem as a Catalyst Angels member and has earned certifications from the Angel Capital Association and Venture Capital University. Driven by a passion for bridging the gap between science and business, she has consulted 100+ science professionals, academics, and entrepreneurs, guiding them through their startup journeys. She has helped these companies secure over $6 million in non-dilutive funding by translating their technological narratives into compelling business stories. She is the Founder and Principal Consultant at Ruby Leaf Media, a science media and communications company. Her mission is to elevate the business story of research. She and her team empower tech accelerators and investors to support their portfolio companies in the STEM fields.
Mary Auge
Director, Healthcare & Life Sciences Commercialization Coach
Ian McClure
Technology Transfer Advisor
Ian McClure is the Associate Vice President for Research, Innovation and Economic Impact for UK Innovate at the University of Kentucky (UK) where he leads efforts to translate UK discoveries for the public good, seek equitable returns on UK intellectual property, create innovative approaches to develop, fund and support opportunities for near-stage research, seek grant funding to enhance UK’s investments in innovation, and expand industry and other collaborative research programs with UK Research and in Kentucky more broadly.
He was Executive Director of the UK Office of Technology Commercialization where he oversaw UK’s innovation, IP and startup portfolios. Ian is an advisory board member for the Oak Ridge Institute, chair of IPwe’s Advisory Committee for University Technology Transfer, PI on two NIH grants, chair-elect for the AUTM Board of Directors, and is a co-founder of Kentucky Commercialization Ventures, a state-funded program to provide tech transfer services to any Kentucky public university without dedicated tech transfer resources. Ian began his career as a M&A and IP transactions attorney.